OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
229356

Bamboos Health Care Holdings Ltd

Employment ServicesVerified

Bamboos Health Care Holdings Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.27, indicating limited leverage. The company's liquidity position is assessed as medium, with a current ratio of 0.92, suggesting potential short-term liquidity constraints. Free cash flow of HKD 4.86 million reflects modest cash generation capacity, while operating cash flow of HKD 38.36 million supports ongoing operations. Profitability metrics show a return on equity of 7.65% and a return on assets of 5.55%, both below the median for the Employment Services industry. The company's operating margin of 32.4% (HKD 24.14 million operating income on HKD 74.40 million revenue) is in line with industry norms, but net margin of 2.36% (HKD 17.54 million net income) suggests pressure from operating expenses. The company operates in a single business segment focused on healthcare staffing in Hong Kong. Revenue is entirely concentrated in the local market, with no disclosed international operations. This geographic concentration exposes the company to regulatory and economic risks specific to Hong Kong. Outlook for the current fiscal year shows a projected revenue increase of 5.0% year-over-year, driven by expanded service offerings in home care and vaccination services. For the next fiscal year, revenue is expected to grow by 3.5%, reflecting cautious optimism in the healthcare staffing market. Risk assessment highlights medium liquidity risk due to the current ratio below 1.0 and a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. The company has not disclosed any material dilution sources in recent filings. Recent filings and transcripts indicate the company is expanding its outreach case assessment and vaccination services, which are expected to contribute to revenue diversification. No material legal or regulatory issues were disclosed in the latest 10-K equivalent filing.

30-day price · 2293-0.02 (-5.0%)
Low$0.36High$0.40Close$0.38As of21 May, 00:00 UTC
Profile
CompanyBamboos Health Care Holdings Ltd
Ticker2293.HK
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryEmployment Services
AI analysis

Business. Bamboos Health Care Holdings Ltd provides healthcare staffing solutions, including private nursing and home care services, to hospitals, social service agencies, and clinics in Hong Kong.

Classification. Bamboos Health Care Holdings Ltd is classified under the Employment Services industry within the Industrial & Commercial Services business sector, with a confidence level of 0.92.

Bamboos Health Care Holdings Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.27, indicating limited leverage. The company's liquidity position is assessed as medium, with a current ratio of 0.92, suggesting potential short-term liquidity constraints. Free cash flow of HKD 4.86 million reflects modest cash generation capacity, while operating cash flow of HKD 38.36 million supports ongoing operations. Profitability metrics show a return on equity of 7.65% and a return on assets of 5.55%, both below the median for the Employment Services industry. The company's operating margin of 32.4% (HKD 24.14 million operating income on HKD 74.40 million revenue) is in line with industry norms, but net margin of 2.36% (HKD 17.54 million net income) suggests pressure from operating expenses. The company operates in a single business segment focused on healthcare staffing in Hong Kong. Revenue is entirely concentrated in the local market, with no disclosed international operations. This geographic concentration exposes the company to regulatory and economic risks specific to Hong Kong. Outlook for the current fiscal year shows a projected revenue increase of 5.0% year-over-year, driven by expanded service offerings in home care and vaccination services. For the next fiscal year, revenue is expected to grow by 3.5%, reflecting cautious optimism in the healthcare staffing market. Risk assessment highlights medium liquidity risk due to the current ratio below 1.0 and a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. The company has not disclosed any material dilution sources in recent filings. Recent filings and transcripts indicate the company is expanding its outreach case assessment and vaccination services, which are expected to contribute to revenue diversification. No material legal or regulatory issues were disclosed in the latest 10-K equivalent filing.
Key takeaways
  • The company maintains a low debt-to-equity ratio of 0.27, indicating a conservative capital structure.
  • Return on equity of 7.65% is below the industry median, suggesting room for improvement in profitability.
  • Revenue is entirely concentrated in Hong Kong, exposing the company to local regulatory and economic risks.
  • Free cash flow of HKD 4.86 million is modest, with operating cash flow of HKD 38.36 million supporting operations.
  • Outlook for the next fiscal year shows a projected 3.5% revenue growth, driven by expanded service offerings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$74.4M
Gross profit$67.9M
Operating income$24.1M
Net income$17.5M
R&D
SG&A
D&A
SBC
Operating cash flow$38.4M
CapEx-$1.8M
Free cash flow$4.9M
Total assets$315.9M
Total liabilities$86.5M
Total equity$229.4M
Cash & equivalents
Long-term debt$62.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$74.4M$24.1M$17.5M$4.9M
FY-1$94.8M$40.7M$30.9M$4.3M
FY-2$126.6M$59.8M$46.9M$21.6M
FY-3$140.3M$73.2M$58.6M-$160.1M
FY-4$109.7M$73.7M$61.0M$45.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$315.9M$229.4M
FY-1$318.1M$218.3M
FY-2$346.8M$222.3M
FY-3$351.3M$210.6M
FY-4$240.8M$194.8M
PeriodOCFCapExFCFSBC
FY0$38.4M-$1.8M$4.9M
FY-1$37.4M-$1.7M$4.3M
FY-2$41.9M-$261.0k$21.6M
FY-3$116.1M-$186.4M-$160.1M
FY-4$49.4M-$22.0k$45.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$229.4M
Net cash-$62.1M
Current ratio0.9
Debt/Equity0.3
ROA5.5%
ROE7.6%
Cash conversion2.2%
CapEx/Revenue-2.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Employment Services · cohort 1 companies
Metric2293Activity
Op margin32.4%1.4% medp25 1.4% · p75 1.4%top quartile
Net margin23.6%2.3% medp25 0.3% · p75 7.7%top quartile
Gross margin91.3%37.2% medp25 37.2% · p75 37.2%top quartile
CapEx / revenue-2.4%3.0% medp25 3.0% · p75 3.0%bottom quartile
Debt / equity27.0%21.3% medp25 4.4% · p75 42.4%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 06:23 UTC#040b3aa3
Market quoteclose HKD 0.39 · shares 0.40B diluted
no public URL
2026-05-04 01:51 UTC#7c41d60c
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 06:24 UTCJob: c1926d0e